see
major
articl
haus
et
al
page
respiratori
ill
pregnanc
well
recogn
anecdot
consid
common
pregnant
women
healthcar
provid
alik
howev
data
describ
incid
impact
common
respiratori
virus
influenza
viru
pregnant
women
extrem
limit
articl
haus
et
al
issu
journal
infecti
diseas
provid
prospect
descript
respiratori
viral
diseas
women
seen
outpati
obstetr
clinic
second
third
trimest
pregnanc
base
symptom
note
women
author
evalu
women
larg
urban
outpati
clinic
viral
caus
acut
respiratori
symptom
clinic
extent
diseas
particip
present
medic
care
although
studi
evalu
incid
respiratori
diseas
popul
prospect
enrol
pregnant
cohort
inform
provid
relev
end
point
futur
epidemiolog
studi
well
vaccin
trial
signific
find
studi
one
third
women
symptom
acut
respiratori
ill
diseas
consist
lower
respiratori
tract
diseas
author
defin
difficulti
breath
short
breath
wheez
cyanosi
morbid
associ
symptom
sign
consider
associ
varieti
respiratori
virus
note
studi
evalu
asymptomat
pregnant
women
well
allow
comparison
respiratori
virus
detect
women
without
symptom
studi
popul
reflect
contemporari
makeup
pregnant
women
unit
state
median
age
year
broad
represent
racial
ethnic
background
common
virus
detect
includ
rhinoviru
coronaviru
respiratori
syncyti
viru
rsv
wellknown
respiratori
virus
high
attack
rate
adult
children
welldescrib
pregnant
women
prior
studi
respiratori
viral
ill
pregnanc
focus
usual
influenza
start
pandem
pregnant
women
identifi
higher
risk
sever
morbid
mortal
due
influenza
compar
nonpregn
adult
influenza
pandem
pregnant
women
influenza
particularli
third
trimest
demonstr
increas
diseas
sever
well
higher
rate
secondari
bacteri
pneumonia
increas
risk
inpati
intens
care
unit
admiss
compar
nonpregn
adult
risk
extend
fetu
higher
rate
stillbirth
miscarriag
preterm
birth
observ
influenza
viru
infect
pregnanc
overal
inactiv
influenza
vaccin
found
safe
immunogen
effect
prevent
influenza
pregnant
women
despit
concern
rel
immunocompromis
state
pregnanc
pregnant
women
shown
achiev
serolog
protect
rate
gener
compar
nonpregn
adult
record
epidemiolog
data
earli
part
pandem
result
pregnant
women
receiv
prioriti
vaccin
unit
state
countri
intern
priorit
influenza
vaccin
pregnanc
world
health
organ
recommend
base
mainli
benefit
pregnant
women
recent
larg
prospect
control
clinic
trial
demonstr
effect
matern
influenza
immun
prevent
diseas
pregnant
women
studi
also
demonstr
reduct
influenza
incid
among
infant
born
vaccin
women
anoth
import
benefit
matern
immun
potenti
benefit
influenza
vaccin
fetu
document
nepal
clinic
trial
site
influenza
present
nearli
yearround
preval
low
birth
weight
preterm
birth
high
repres
south
asian
popul
studi
frequenc
low
birth
weight
significantli
lower
among
infant
born
vaccin
women
birthweight
effect
pronounc
period
high
influenza
viru
circul
match
circul
viru
vaccin
strain
present
studi
well
previou
random
control
trial
matern
influenza
immun
bangladesh
show
effect
influenza
vaccin
improv
fetal
outcom
respiratori
virus
increasingli
recogn
etiolog
agent
communityacquir
pneumonia
adult
recent
populationbas
activ
surveil
studi
identifi
rhinoviru
influenza
viru
common
pathogen
adult
requir
hospit
studi
evalu
role
respiratori
virus
influenza
viru
pregnanc
rsv
infect
pregnanc
remain
poorli
character
reflect
major
gap
epidemiolog
understand
address
introduct
rsv
vaccin
healthi
adult
popul
age
year
rsv
shown
commonli
acquir
caus
symptomat
respiratori
ill
increas
symptom
durat
less
fever
compar
influenza
us
studi
adult
rsv
lower
respiratori
tract
symptom
defin
tracheobronch
bronchiti
wheez
proport
symptomat
rsv
infect
like
even
higher
among
pregnant
women
evidenc
studi
owe
increas
risk
exposur
young
children
decreas
cardiopulmonari
reserv
previou
studi
rsv
pregnanc
primarili
case
report
secondari
analys
influenza
vaccin
trial
use
data
influenza
vaccin
trial
determin
incid
infect
due
rsv
respiratori
virus
multipl
limit
includ
use
influenzalik
ill
ili
criteria
respiratori
ill
surveil
influenza
season
ili
criteria
tradit
base
presenc
fever
cough
andor
sore
throat
known
major
case
rsv
infect
adult
afebril
addit
influenza
rsv
season
often
overlap
like
lead
underestim
rsv
infect
burden
sampl
ongo
period
influenza
viru
circul
two
recent
matern
influenza
studi
nepal
south
africa
evalu
incid
matern
respiratori
diseas
due
rsv
pregnanc
nepal
women
fever
respiratori
symptom
nasal
swab
specimen
collect
rsv
infect
preval
incid
personyear
overal
south
africa
rsv
infect
preval
base
presenc
respiratori
symptom
much
higher
overal
incid
personyear
importantli
none
matern
case
rsv
infect
south
africa
trial
associ
fever
rsv
infect
associ
increas
risk
low
birth
weight
preterm
birth
either
south
africa
nepal
studi
although
number
women
studi
rsv
small
respiratori
virus
includ
rhinoviru
coronaviru
parainfluenza
virus
human
metapneumoviru
recent
identifi
caus
febril
respiratori
viral
infect
pregnant
women
rhinoviru
identifi
common
caus
ili
pregnant
women
middl
eastern
respiratori
syndrom
sever
acut
respiratori
syndrom
coronavirus
describ
caus
sever
diseas
pregnant
women
respiratori
virus
commonli
detect
matern
influenza
vaccin
trial
nepal
women
fever
respiratori
symptom
viru
detect
major
febril
respiratori
ill
episod
pregnant
women
frequenc
care
seek
physician
hospit
ill
episod
rang
ill
episod
base
viru
signific
find
region
world
medic
care
extrem
limit
difficult
access
febril
rhinoviru
human
metapneumoviru
infect
associ
increas
risk
fetal
growth
restrict
studi
suggest
deleteri
effect
matern
viral
infect
fetu
may
restrict
pregnant
women
influenza
matern
immun
increasingli
recogn
safe
effect
intervent
boost
antibodi
level
pregnanc
increas
level
transplacent
antibodi
transfer
fetu
infant
sever
month
old
gener
unabl
mount
effect
immun
respons
vaccin
infect
requir
sever
dose
vaccin
leav
window
vulner
seriou
infect
matern
vaccin
may
increas
matern
subsequ
fetal
antibodi
titer
potenti
protect
level
therebi
protect
infant
critic
window
multipl
rsv
vaccin
candid
alreadi
clinic
trial
includ
rsv
nanoparticl
vaccin
alum
adjuv
evalu
larg
clinic
trial
involv
pregnant
women
vaccin
third
trimest
pregnanc
clinicaltrialsgov
identifi
rsv
vaccin
candid
also
intend
use
pregnant
women
world
health
organ
estim
rsv
vaccin
licens
next
year
studi
progress
find
studi
report
issu
provid
import
background
data
understand
potenti
effect
matern
vaccin
protect
pregnant
women
fetus
investig
impact
respiratori
virus
pregnanc
set
worthi
studi
sensit
molecular
diagnost
test
becom
wide
avail
develop
new
vaccin
antivir
monoclon
antibodi
respiratori
virus
grow
